|

Ropivacaine 0.2% Injectable Solution Clinical Trials

4 actively recruiting trials

Also known as: Ropivacaine hydrochloride

Pipeline

Phase 4: 1

Top Sponsors

  • Poznan University of Medical Sciences4

Indications

  • Arthritis4
  • Hip Osteoarthritis3
  • Arthropathy of Hip1
  • Hip Arthritis1
  • Hip Arthropathy1

Other4 trials

Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA
N/A
PENG Block Optimization: Volume and Dexamethasone Effects
Phase 4
PENG Block With Dexmedetomidine in Older Adults
N/A
Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.